Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 335, pseudogene (RNU6-335P)
- Target
- RNU6-335P
- Molecular classification
- Other (noncoding RNA pseudogene, more specifically a small nuclear RNA pseudogene)
01
Overview
RNU6-335P is a pseudogene corresponding to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is involved in the essential process of nuclear pre-mRNA splicing, serving as a key component of the spliceosome complex. However, as a pseudogene, RNU6-335P does not encode a functional RNA molecule and is presumed to be transcriptionally inactive or nonfunctional. Pseudogenes are often produced by duplication or retrotransposition events, and while some may play roles in gene regulation or have residual transcriptional activity, there is no evidence that RNU6-335P is involved in any biological process, therapeutic targeting, or disease mechanism. Its existence reflects genome evolution rather than active cellular function.
- Other names
- RNU6-335PU6 snRNA pseudogene 335RNA, U6 small nuclear 335, pseudogene
02
Mechanism of action
None (no mechanisms because there are no drugs targeting this pseudogene)
03
Biological functions
None (as a pseudogene, it is generally nonfunctional)For functional U6 snRNA, the role is in nuclear mRNA splicing, but the pseudogene itself does not participate in this process.
04
Disease associations
Other (no established disease roles or associations for this specific pseudogene)Some pseudogenes may occasionally be relevant as biomarkers in cancer or other diseases, but there is no evidence for RNU6-335P.
05
Safety considerations
None (no safety concerns or therapeutic challenges relevant)
06
Interacting drugs
None (there are no drugs known to interact with this pseudogene)
07
Biomarkers
None (not established as a biomarker for disease or therapeutic efficacy)
Beyond the preview
Go deeper on RNA, U6 small nuclear 335, pseudogene (RNU6-335P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 335, pseudogene (RNU6-335P).